Bradley Atkinson

Bradley Atkinson currently serves as the Executive Director, National Director Solid Tumor Field Medical Affairs at AbbVie, leading the national Field Medical Affairs team for oncology therapeutic launches and overseeing clinical-to-commercial transition strategies following the acquisition of ImmunoGen. Prior to this, Atkinson held the position of Executive Director, Medical Affairs National Field Lead at ImmunoGen, and Regional Director Medical Science Liaisons at AstraZeneca, where successes included expanded indication launches in thoracic oncology. At Merck, Atkinson guided MSL teams for key launches and developed excellence models for Field Medical. Earlier career experience includes managerial and clinical roles at MD Anderson Cancer Center. Educational credentials include a Doctor of Pharmacy (PharmD) from The University of Kansas and an MBA from Texas Woman's University, along with ASHP residencies in Infectious Diseases and Pharmacy Practice.